Russ Hawkinson

SVP Finance

Professional Overview
Russ Hawkinson is an accomplished finance executive with over 30 years of experience in the biotechnology and pharmaceutical industry. As the Senior Vice President of Finance at Mozart Therapeutics, Inc., he is responsible for leading the company's financial strategy, overseeing financial operations, and driving value creation for key stakeholders.

Experience Summary

Current Role
As the SVP of Finance at Mozart Therapeutics, Inc., Russ is instrumental in guiding the company's financial direction and ensuring efficient allocation of resources. He oversees all aspects of financial planning, reporting, and risk management, while collaborating closely with the executive team to support the company's strategic growth initiatives. Under his leadership, Mozart Therapeutics has achieved significant milestones, including securing multiple financing rounds and managing the successful integration of a recent acquisition.

Career Progression
Prior to his current role, Russ held senior finance positions at several prominent biotechnology companies. As the SVP of Finance at Silverback Therapeutics, he played a pivotal role in the company's successful IPO and the subsequent expansion of its pipeline. As the CFO at OncoResponse and Theraclone Sciences, he led the companies' financial operations, secured funding, and supported the advancement of their clinical programs. Earlier in his career, Russ held finance leadership roles at Cell Therapeutics, Inc. and Corixa, where he contributed to the companies' growth and strategic initiatives.

Academic Background
Russ holds a Bachelor's degree in Accounting from the University of Washington and is a Certified Public Accountant (CPA).

Areas of Expertise

• Financial planning and analysis

• Fundraising and capital markets

• M&A and integration

• Risk management and internal controls

• Financial reporting and compliance

• Biotechnology and pharmaceutical industry expertise

Professional Impact
Throughout his career, Russ has played a pivotal role in securing and managing significant financing for his employers, enabling them to advance their drug development pipelines and achieve key milestones. He has a proven track record of driving financial efficiencies, implementing robust internal controls, and providing strategic financial guidance to support the long-term growth and success of his organizations.

Conclusion
With his extensive finance expertise, industry knowledge, and demonstrated leadership, Russ Hawkinson is a valuable asset to Mozart Therapeutics, Inc. as the company continues to advance its innovative therapeutic pipeline and create value for its stakeholders.